DIABETES OBESITY & METABOLISM, vol.6, no.1, pp.50-55, 2004 (SCI-Expanded)
Article / Article
DIABETES OBESITY & METABOLISM
Science Citation Index Expanded (SCI-EXPANDED), Scopus
echocardiography, heart valves, pulmonary artery pressure, sibutramine, HYPERTENSION, TRIAL, FENFLURAMINE, EFFICACY, AGENTS, DRUGS, RISK
Bezmialem Vakıf University Affiliated:
Aim: Obesity is a major global public health problem. Previous drugs (dexfenfluramine and fenfluramine) used for the treatment of obesity have been withdrawn due to various cardiac side effects. Sibutramine is an anti-obesity agent. The purpose of this study was to assess cardiac valve disease and pulmonary artery pressure (PAP) of the patients who used once daily doses of sibutramine.